These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14290989)

  • 1. [RESULTS OBTAINED WITH HYPACOM IN THE TREATMENT OF PERIPHERAL ANGIOPATHIES].
    GARCIAZOZAYA R
    Cir Ginecol Urol; 1965; 19():27-38. PubMed ID: 14290989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventive action of pH 203 on thrombophlebitis of the lower limbs in surgical patients].
    STALPORT J; NICCLAS E; DEMELENNE A; HORECZKI G
    Acta Chir Belg; 1962 Feb; 61():138-48. PubMed ID: 13916134
    [No Abstract]   [Full Text] [Related]  

  • 3. [DRUG THERAPY OF OBLITERATIVE PROCESSES OF PERIPHERAL ARTERIOPATHIES].
    STRANO A
    Med Welt; 1965 Mar; 12():603-9. PubMed ID: 14293113
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of peripheral vascular diseases with hydrogenated ergot alkaloids].
    ZOZAYA RG
    Praxis; 1956 Jun; 45(25):575-8. PubMed ID: 13349989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hydrogenated ergot alkaloids (hydergin) in therapy of peripheral circulatory disorders].
    EHREN H
    Dtsch Med Wochenschr; 1951 Oct; 76(43):1334-7. PubMed ID: 14896779
    [No Abstract]   [Full Text] [Related]  

  • 6. [INTRA-ARTERIAL PRISCOL AND HYDERGIN IN PERIPHERAL VASCULAR DISEASE)].
    WEISER HI
    Harefuah; 1964 Jun; 66():407-10. PubMed ID: 14173940
    [No Abstract]   [Full Text] [Related]  

  • 7. [THERAPY OF APOPLECTIC INSULT IN THE ACUTE PHASE, ITS SEQUELAE AND DIFFUSE SCLEROTIC ENCEPHALOPATHIES WITH PH 203].
    CORTI L; SCARDIGLI G; FRANCHI G
    Clin Ter; 1965 May; 33():304-11. PubMed ID: 14347579
    [No Abstract]   [Full Text] [Related]  

  • 8. [NEUROPLEGIA ASSOCIATED WITH ENZYME INHIBITORS IN THE TREATMENT OF SEVERE HEMORRHAGIC ACUTE PANCREATITIS].
    SETBON L; STROZ G
    Acta Gastroenterol Belg; 1964; 27():347-50. PubMed ID: 14212711
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and therapeutic investigations with certain new hydrogenated ergot alkaloids in peripheral vascular disorders.
    KAPPERT A; HADRON W
    Angiology; 1950 Dec; 1(6):520-9. PubMed ID: 14790321
    [No Abstract]   [Full Text] [Related]  

  • 10. [DRUG THERAPY OF PARAPLEGIC CIRCULATORY DISORDERS IN OLD AGE. OBSERVATIONS AND LATE RESULTS].
    BARTSCH W
    Munch Med Wochenschr; 1965 Feb; 107():426-30. PubMed ID: 14267954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thromboembolism prevention in surgery. Results with panthesin-hydergin (PH 203) in 1048 patients].
    MAGISTRIS F; BRENNER GL
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1960; 293():353-64. PubMed ID: 14419855
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of PH 203 (panthesine hydergine) in thrombo-embolic diseases in obstetrics and gynaecology.
    GANS B; ECKERLING B; SAX B
    S Afr Med J; 1959 Aug; 33():707-9. PubMed ID: 13826317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of myocardial infarct in old age with panthesin and hydergine (PH 203)].
    THEINL K
    Wien Med Wochenschr; 1960 Mar; 110():209-12. PubMed ID: 13837684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diminution of postoperative thromboembolic complications by prophylaxis with panthesine-hydergin (PH 203)].
    MOSER H
    Wien Klin Wochenschr; 1959 Aug; 71():635-7. PubMed ID: 14424531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylaxis and treatment of postoperative thromboses and embolisms by PH 203].
    SELDESLACHTS J
    Rev Med Liege; 1962 Apr; 17():260-4. PubMed ID: 13910407
    [No Abstract]   [Full Text] [Related]  

  • 16. [Additional observations on the treatment of myocardial infarct in old age with Panthesin and Hydergin (PH 203)].
    THEINL K
    Wien Klin Wochenschr; 1961 Feb; 73():143-5. PubMed ID: 13776197
    [No Abstract]   [Full Text] [Related]  

  • 17. [MODIFICATIONS OF THE VASCULAR EFFECTS OF THE GANGLIOPLEGICS BY THE ERGOT ALKALOIDS].
    BRUGGER A; ESPLUGUES J
    Med Esp; 1963 Dec; 50():383-96. PubMed ID: 14112389
    [No Abstract]   [Full Text] [Related]  

  • 18. [MODIFICATIONS OF THE VASCULAR EFFECTS OF ERGOT ALKALOIDS BY GANGLIOPLEGICS].
    BRUGGER A; ESPLUGUES J
    Med Esp; 1964 Jan; 51():23-35. PubMed ID: 14135750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with panthesin-hydergine (PH 203) and exacthin (ACTH) in disorders of retinal circulation].
    ORBAN T
    Ophthalmologica; 1960 Dec; 140():388-400. PubMed ID: 13731101
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of peripheral vascular diseases with hydrogenated alkaloids of ergot (hydergine)].
    GARCIA ZOZAYA R
    Rev Clin Esp; 1955 May; 57(4):235-41. PubMed ID: 13255203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.